Interactions between P-glycoprotein and drugs used in the supportive care of AML patients.

被引：0
|
作者：
Möllgård, L
Hellberg, E
Smolowicz, A
Paul, C
Tidefelt, U
机构：
[1] Huddinge Univ Hosp, Dept Hematol, Stockholm, Sweden
[2] Orebro Med Ctr Hosp, Dept Med, Orebro, Sweden
[3] Orebro Med Ctr Hosp, Dept Transfus Med, Orebro, Sweden
[4] Karolinska Inst, S-10401 Stockholm, Sweden
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1340
引用
收藏
页码：310A / 310A
页数：1
相关论文
共 50 条
  • [21] The Basis of Anthracycline Drugs Transport by P-Glycoprotein
    Nguyen, Phuong H.
    Sigdel, Krishna P.
    Kings, Gavin M.
    Roberts, Arthur G.
    FASEB JOURNAL, 2019, 33
  • [22] Molecular Modeling of P-Glycoprotein and Related Drugs
    Ilza Pajeva
    Christoph Globisch
    Romy Fleischer
    Ivanka Tsakovska
    Michael Wiese
    Medicinal Chemistry Research, 2005, 14 : 106 - 117
  • [23] The contribution of P-glycoprotein to clinical pharmacokinetic interactions between lenalidomide and temsirolimus
    Yang, Xiaoxia
    Craig, Hofmeister C.
    Rozewski, Darlene M.
    Lee, Seungsoo
    Chen, Ping
    Johnson, Amy J.
    Liu, Zhongfa
    Hade, Erinn M.
    Ji, Jia
    Schaaf, Larry J.
    Benson, Don M.
    Kraut, Eric H.
    Hicks, William J.
    Chan, Kenneth K.
    Chen, Ching-Shih
    Farag, Sherif S.
    Grever, Michael R.
    Byrd, John C.
    Phelps, Mitch A.
    CANCER RESEARCH, 2011, 71
  • [24] Mutually co-operative interactions between modulators of P-glycoprotein
    Shao, YM
    Ayesh, S
    Stein, WD
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1360 (01): : 30 - 38
  • [25] The P-Glycoprotein Transport System and Cardiovascular Drugs
    Wessler, Jeffrey D.
    Grip, Laura T.
    Mendell, Jeanne
    Giugliano, Robert P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (25) : 2495 - 2502
  • [26] Molecular modeling of P-glycoprotein and related drugs
    Pajeva, I
    Globisch, C
    Fleischer, R
    Tsakovska, I
    Wiese, M
    MEDICINAL CHEMISTRY RESEARCH, 2005, 14 (02) : 106 - 117
  • [27] P-GLYCOPROTEIN INHIBITION EXACERBATES PACLITAXEL NEURONAL TOXICITY IN NEURONS AND CANCER PATIENTS.
    Stage, T.
    Khalaf, S.
    Steffensen, V.
    Hammer, H.
    Xiong, C.
    Nielsen, F.
    Poetz, O.
    Svenningsen, A.
    Rodriguez-Antona, C.
    Kroetz, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S118 - S118
  • [28] CLINICAL SIGNIFICANT P-GLYCOPROTEIN DRUG INTERACTIONS?
    Lee, Caroline A.
    Fenner, Katherine S.
    Kempshall, Sarah
    Cook, Jack
    Ware, Joseph Alan
    Troutman, Matthew D.
    DRUG METABOLISM REVIEWS, 2008, 40 : 208 - 208
  • [29] Computer Evaluation of Drug Interactions with P-Glycoprotein
    Lagunin, A. A.
    Gloriozova, T. A.
    Dmitriev, A. V.
    Volgina, N. E.
    Poroikov, V. V.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2013, 154 (04) : 521 - 524
  • [30] Computer Evaluation of Drug Interactions with P-Glycoprotein
    A. A. Lagunin
    T. A. Gloriozova
    A. V. Dmitriev
    N. E. Volgina
    V. V. Poroikov
    Bulletin of Experimental Biology and Medicine, 2013, 154 : 521 - 524
12345